Drug Firm That Hiked Prices By 6,000% Paid Shareholders £400 Million

News

“A pharmaceuticals firm that inflated thyroid drug prices by up to 6,000% over a decade paid out more than £400m to shareholders and directors during the same period.” [Source: Medicalexpress.com]

Comment

The take-home message of this news story, yet again, is that the pharmaceutical industry prioritizes the interests of its shareholders over human health. This greed-driven disregard for the interests of patients and national healthcare systems has resulted in the pharmaceutical industry’s annual global income being expected to reach $1.6 trillion by 2025.

By means of a comparison, if the pharmaceutical industry was a country, a gross domestic product (GDP) of $1.6 trillion would place it among the world’s richest nations and give it membership of the G20. It therefore goes without saying that, behind the scenes, this sort of money buys the pharmaceutical industry a great deal of political influence. To permit such a relationship between drug companies and politicians is neither in the interests of taxpayers nor patients.

To find the facts about the pharmaceutical industry, check out the ‘Laws of the Pharmaceutical Industry’ feature on our website – and then share it widely on social media so that your followers can also have their eyes opened to the truth.

The post Drug Firm That Hiked Prices By 6,000% Paid Shareholders £400 Million appeared first on Dr. Rath Health Foundation.